{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:09:37Z","timestamp":1790744977032,"version":"4.1.0"},"reference-count":6,"publisher":"BMJ","funder":[{"name":"Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project","award":["2026ZD01912300"],"award-info":[{"award-number":["2026ZD01912300"]}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,7,5]]},"DOI":"10.1136\/gutjnl-2026-339913","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:25:23Z","timestamp":1784136323000},"page":"gutjnl-2026-339913","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?"],"prefix":"10.1136","author":[{"given":"Tianhao","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Infectious Disease Center, School of Basic Medicine, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Infectious Disease Center, School of Basic Medicine, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abudurexiti","family":"Abulaiti","sequence":"additional","affiliation":[{"name":"Institute of Medical Technology, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Tianjin Second People\u2019s Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Liu","sequence":"additional","affiliation":[{"name":"MOE Key Laboratory of Model Animal for Disease Study, State Key Laboratory of Pharmaceutical Biotechnology, Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Model Animal Research Center, School of Medicine, Nanjing University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shenzhen Third People\u2019s Hospital, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3214-0038","authenticated-orcid":false,"given":"Yongfeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1832-3209","authenticated-orcid":false,"given":"Fengmin","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural and Biomimetic Drugs, Department of Microbiology & Infectious Disease Center, School of Basic Medicine, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2026071510251738000_gutjnl-2026-339913v1.1","doi-asserted-by":"crossref","unstructured":"Lau D-Y , Kim ES , Wang Z , et al . Differential intrahepatic integrated HBV DNA patterns between HBeAg-positive and HBeAg-negative chronic hepatitis B. Gut 2026;gutjnl\u20132025. doi:10.1136\/gutjnl-2025-337127","DOI":"10.1136\/gutjnl-2025-337127"},{"key":"2026071510251738000_gutjnl-2026-339913v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2007.12.024"},{"key":"2026071510251738000_gutjnl-2026-339913v1.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101144","article-title":"Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretion","volume":"6","author":"Gu","year":"2024","journal-title":"JHEP Rep"},{"key":"2026071510251738000_gutjnl-2026-339913v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.014"},{"key":"2026071510251738000_gutjnl-2026-339913v1.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.019"},{"key":"2026071510251738000_gutjnl-2026-339913v1.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100664","article-title":"Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells","volume":"5","author":"Aggarwal","year":"2023","journal-title":"JHEP Rep"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2026-339913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:25:24Z","timestamp":1784136324000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2026-339913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":6,"alternative-id":["10.1136\/gutjnl-2026-339913"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2026-339913","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}